These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4018848)

  • 21. Calcium channel blocking agents. Council on scientific affairs.
    JAMA; 1983 Nov; 250(18):2522-4. PubMed ID: 6685194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of corinfar and finoptin on lipid peroxidation].
    Zhuravlev AK; Murashko VV; Kamchatnov PR
    Klin Med (Mosk); 1988 Apr; 66(4):35-7. PubMed ID: 3398447
    [No Abstract]   [Full Text] [Related]  

  • 23. Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Danish Study Group on Verapamil in Myocardial Infarction.
    Hansen JF
    Eur Heart J; 1986 Oct; 7(10):910-1. PubMed ID: 3792353
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical use of calcium channel blockers.
    Galle JS
    Conn Med; 1983 Oct; 47(10):605-10. PubMed ID: 6627936
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium antagonists in the treatment of arterial hypertension].
    Chlewicka I; Wasowska T
    Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of cardioplegic myocardial protection with calcium entry blockers.
    Guyton RA; Dorsey LM; Kates RA; Hatcher CR
    J Med Assoc Ga; 1984 Oct; 73(10):707-11. PubMed ID: 6502035
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the effects of calcium antagonists on respiration mechanics in patients with occlusive ventilation impairment].
    Frank-Piskorska A; Wasek Z; Malinowski R
    Wiad Lek; 1989 Mar; 42(5):278-83. PubMed ID: 2815744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group.
    Schartl M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S79-81. PubMed ID: 1282620
    [No Abstract]   [Full Text] [Related]  

  • 32. [Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?].
    Ennezat PV; Auffray JL; Darchis J; Rousselle M; Gonin X; Aubert JM; Bauchart JJ; Bauters C; Van Belle E; Asseman P
    Therapie; 2006; 61(3):191-4. PubMed ID: 16989118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical uses of calcium antagonists.
    Hope RR; Lazzara R
    Adv Intern Med; 1982; 27():435-52. PubMed ID: 6462036
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use of calcium channel blockers.
    Mayer WP
    Alaska Med; 1984; 26(1):10-2. PubMed ID: 6539573
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative effects of calcium channel blockers in an experimental colitis model in rats.
    Zeytunlu M; Korkut M; Akgün E; Firat O; Aynaci M; Içöz G; Kiliç M; Ersin S; Ozütemiz O
    Turk J Gastroenterol; 2004 Dec; 15(4):243-9. PubMed ID: 16249979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
    Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Brenna S; Bonacina E; Vignati S
    Fundam Clin Pharmacol; 2004 Dec; 18(6):657-67. PubMed ID: 15548237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blockers and mortality in elderly patients with myocardial infarction.
    Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC
    Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.